Presentation from BIO Pacific Rim Conference December 2013, providing an overview of regulations affecting industrial biotechnology, and presenting a case study of an MCAN successfully submitted to the EPA for a genetically modified cyanobacterium for production of ethanol.
BAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
David Glass Regulatory Presentation and Case Study BIO Pac Rim Conference December 2013
1. David J. Glass, Ph.D.
D. Glass Associates, Inc.
BIO Pacific Rim Summit
December 10, 2013
2. Presentation Overview
Overview: U.S. and international biotechnology
regulation
EPA TSCA biotechnology regulation and its impact on
biofuel and bio-based chemical production
Case Study: Joule Unlimited Technologies, Inc.: EPA
review of Microbial Commercial Activity Notice (MCAN)
for modified cyanobacteria for ethanol production
D. Glass Associates, Inc.
3.
4. Overview of U.S. Biotechnology
Regulation
Environmental Protection Agency
Microbial pesticides, plant pesticides.
Engineered microorganisms used for other industrial
purposes.
Modified microorganisms, algae for biofuel, bio-based chemical production
U.S. Department of Agriculture
Transgenic plants, plant-produced industrial products.
Transgenic feedstocks for fuel, chemical production
Food and Drug Administration
Foods, feed, food additives, pharmaceuticals
Microbial biomass used for animal feed
D. Glass Associates, Inc.
5. Overview: USDA Biotechnology
Regulations
Regulations issued in 1987 (7 CFR Part 340) cover environmental
uses, interstate movement of “potential plant pests”.
Historically, these rules have covered outdoor field trials or
commercial growth of transgenic plants in agriculture and
industrial/pharmaceutical production.
Numerous field trials of transgenic energy crops have also taken
place under these regulations.
Major USDA decisions (e.g. commercial approvals) require
environmental assessment for NEPA compliance.
USDA rules would apply to transgenic plants, and possibly
open-pond uses of modified algae.
D. Glass Associates, Inc.
6. International Biotechnology Regulation
European Union. Applicable national government approval would be
required under “Contained Use” Directive 2009/41/EC or “Environmental
Release” Directive 2001/18/EC.
Canada. Industrial uses of modified organisms may fall under the New
Substances Notification regulations under the Canadian Environmental
Protection Act.
Australia. Under the Gene Technology Act and its regulations, both
contained and non-contained uses of modified microorganisms would
require a license from the government.
In many other countries, biotechnology laws are based on the principles of
the Cartagena Protocol on Biosafety, part of the Convention on Biological
Diversity.
D. Glass Associates, Inc.
9. EPA TSCA Biotechnology Rule:
Overview
Regulations under the Toxic Substances Control Act (TSCA) at 40
CFR Part 725 cover “new microorganisms” not regulated
elsewhere in the federal government.
“New microorganisms” defined as “intergeneric”:
i.e., containing deliberate combinations of coding nucleic acids
from more than one taxonomic genus.
Many recombinant microorganisms will not meet this
definition, and not be covered by these rules.
Most research and pilot projects are not regulated if suitably
contained. Commercial use or importation requires 90 day
advance notification to EPA.
D. Glass Associates, Inc.
10. EPA TSCA Biotechnology Rule:
R&D (“Small Quantities”) Exemption
R&D uses of “new microorganisms” may qualify for
exemption, if used “solely for R&D” in a suitably “contained
structure”.
Applicant must adopt procedures at the facility for controlled
access, inactivation of wastes, emission controls, worker
notification.
Exemption applies to R&D by for-profit entities, usually
including pilot plants.
Open-pond algae reactors may not be judged to be “contained
structures”; non-contained uses may require EPA notification
and review via TERA process prior to commencement.
D. Glass Associates, Inc.
11. EPA TSCA Biotechnology Rule:
TSCA Experimental Release Applications
TERA must be filed 60 days before proposed outdoor use.
There have been 25 TERAs submitted since 1997 for
small-scale, outdoor R&D of engineered microorganisms.
All but 3 have been approved.
These have included agricultural microorganisms,
microbes to be used for bioremediation or for detection
of hazardous contaminants in soil.
No TERAs to date for fuel or chemical processes.
TERAs would provide stepwise review for any proposed
uses of modified algae in open ponds.
D. Glass Associates, Inc.
12. EPA TSCA Biotechnology Rule: Microbial
Commercial Activity Notices (MCANs)
Commercial use or importation of “new microorganisms”
requires MCAN reporting at least 90 days before commencing
commercialization or importing microbe.
MCAN requires submission of data to EPA.
Microorganism identity, construction and properties.
Potential health and environmental effects.
Information about the industrial
process, control/containment measures, worker
exposure, possible environmental release.
EPA review, clearance of MCAN authorizes commercial use.
D. Glass Associates, Inc.
13. EPA TSCA Biotechnology Rule:
Biofuel, Bio-Based Chemical MCANs
Over 50 MCANs reviewed since 1997, including:
Numerous MCANs for industrial enzymes (most using
Trichoderma reesei as host organism).
Several MCANs for production of ethanol from species including
E. coli, Klebsiella oxytoca, S. cerevisiae, Z. mobilis.
MCANs for production of various bio-based chemicals.
MCAN filing activity has significantly increased in the last several
years: at least 6-8 filings per year in FY 2011, 2012, 2013.
D. Glass Associates, Inc.
25. Thank you very much
David J. Glass, Ph.D.
D. Glass Associates, Inc.
124 Bird Street
Needham, MA 02492
Phone 617-653-9945
dglass@dglassassociates.com
www.dglassassociates.com
D. Glass Associates, Inc.
Notes de l'éditeur
Joule: founded in 2007Developing a novel gas-to-liquid platform to produce valuable productsUsing sunlight and CO2 as the inputs
Joule is doing so by creating programmable biocatalysts –Modified cyanobacteria engineered with desired pathways.To be used in integrated, proprietary system,To produce ethanol, diesel and other chemicals.
Important to note that Joule is developing an integrated system, consisting not only of the novel biocatalysts and proprietary photobioreactors, but also including the infrastructure needed to produce and purify products.
First commercial facility is in Hobbs, NMDemo plant, in operation for over one year.Using this plant to advance to full-scale process demonstration.This will likely be the first site of commercial ethanol production.